ProfileGDS4718 / 242999_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 25% 25% 34% 24% 23% 26% 22% 21% 20% 25% 25% 22% 27% 28% 26% 24% 27% 30% 24% 23% 24% 20% 25% 25% 27% 28% 23% 25% 21% 26% 24% 27% 26% 26% 22% 25% 30% 20% 23% 31% 28% 26% 26% 31% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3457525
GSM549102patient 115, normal, homogenized [OPG study]4.3440125
GSM549104patient 119, normal, homogenized [OPG study]4.7235834
GSM549108patient 138, normal, homogenized [OPG study]4.3408324
GSM549119patient 077, normal, homogenized [OPG study]4.2476823
GSM549133patient 032, cancer, homogenized [OPG study]4.3022326
GSM549139patient 042, cancer, homogenized [OPG study]4.2163422
GSM549099patient 107, normal, homogenized [OPG study]4.1891121
GSM549109patient 139, normal, homogenized [OPG study]4.1672420
GSM549110patient 046, normal, homogenized [OPG study]4.3410825
GSM549114patient 063, normal, homogenized [OPG study]4.2917325
GSM549122patient 082, normal, homogenized [OPG study]4.2191322
GSM549134patient 033, cancer, homogenized [OPG study]4.4131227
GSM549136patient 036, cancer, homogenized [OPG study]4.4001128
GSM549140patient 044, cancer, homogenized [OPG study]4.3422726
GSM549111patient 047, normal, homogenized [OPG study]4.2833724
GSM549113patient 057, normal, homogenized [OPG study]4.3511227
GSM549132patient 031, cancer, homogenized [OPG study]4.5226130
GSM549137patient 038, cancer, homogenized [OPG study]4.2768924
GSM549142patient 047, cancer, homogenized [OPG study]4.3511223
GSM549100patient 110, normal, homogenized [OPG study]4.2964824
GSM549107patient 135, normal, homogenized [OPG study]4.1144320
GSM549115patient 068, normal, homogenized [OPG study]4.2971425
GSM549116patient 072, normal, homogenized [OPG study]4.3222925
GSM549120patient 078, normal, homogenized [OPG study]4.4298427
GSM549131patient 030, cancer, homogenized [OPG study]4.4033928
GSM549118patient 074, normal, homogenized [OPG study]4.2553523
GSM549129patient 027, cancer, homogenized [OPG study]4.3422725
GSM549123patient 088, normal, homogenized [OPG study]4.1888221
GSM549124patient 006, cancer, homogenized [OPG study]4.4122926
GSM549126patient 015, cancer, homogenized [OPG study]4.3057524
GSM549128patient 025, cancer, homogenized [OPG study]4.4021527
GSM549103patient 117, normal, homogenized [OPG study]4.4176226
GSM549117patient 073, normal, homogenized [OPG study]4.3422726
GSM549138patient 041, cancer, homogenized [OPG study]4.2125922
GSM549141patient 045, cancer, homogenized [OPG study]4.2956125
GSM549130patient 028, cancer, homogenized [OPG study]4.5482930
GSM549101patient 111, normal, homogenized [OPG study]4.1709420
GSM549105patient 128, normal, homogenized [OPG study]4.2665623
GSM549106patient 134, normal, homogenized [OPG study]4.5222231
GSM549112patient 048, normal, homogenized [OPG study]4.4590228
GSM549125patient 011, cancer, homogenized [OPG study]4.3830226
GSM549127patient 024, cancer, homogenized [OPG study]4.3522126
GSM549135patient 035, cancer, homogenized [OPG study]4.5539931